Skip to main content

Gefitinib bests chemo as adjuvant therapy for early EGFR-mutant NSCLC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Gefitinib bests chemo as adjuvant therapy for early EGFR-mutant NSCLC

User login

Username

Password

Reset your password

Type	Lead	score